MA57215B1 - Compounds comprising a nitrile as antivirals for the treatment of coronavirus infection - Google Patents

Compounds comprising a nitrile as antivirals for the treatment of coronavirus infection

Info

Publication number
MA57215B1
MA57215B1 MA57215A MA57215A MA57215B1 MA 57215 B1 MA57215 B1 MA 57215B1 MA 57215 A MA57215 A MA 57215A MA 57215 A MA57215 A MA 57215A MA 57215 B1 MA57215 B1 MA 57215B1
Authority
MA
Morocco
Prior art keywords
compounds
antivirals
nitrile
coronavirus infection
treatment
Prior art date
Application number
MA57215A
Other languages
French (fr)
Inventor
Patrick Robert Verhoest
Martin Youngjin Pettersson
Dafydd Rhys Owen
Xiaojing Yang
Jamison Bryce Tuttle
Matthew Richard Reese
Matthew Forrest Sammons
Liuqing Wei
Qingyi Yang
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority claimed from PCT/IB2021/057281 external-priority patent/WO2021250648A1/en
Publication of MA57215B1 publication Critical patent/MA57215B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

L'invention concerne des composés de formule (i'') dans laquelle r, r1, r2, r3, p, q et q' sont tels que définis dans la description, des compositions pharmaceutiques comprenant les composés, des procédés de traitement d'une infection à coronavirus, telle que la covid-19 chez un patient, par administration de quantités thérapeutiquement efficaces des composés, et des procédés d'inhibition ou de prévention de la réplication de coronavirus tels que le sars-cov-2 avec les composés.The invention relates to compounds of formula (i'') wherein r, r1, r2, r3, p, q and q' are as defined in the description, pharmaceutical compositions comprising the compounds, methods of treating coronavirus infection, such as covid-19 in a patient, by administering therapeutically effective amounts of the compounds, and methods of inhibiting or preventing replication of coronaviruses such as sars-cov-2 with the compounds.

MA57215A 2020-09-03 2021-08-06 Compounds comprising a nitrile as antivirals for the treatment of coronavirus infection MA57215B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063073982P 2020-09-03 2020-09-03
PCT/IB2021/057281 WO2021250648A1 (en) 2020-09-03 2021-08-06 Nitrile-containing antiviral compounds

Publications (1)

Publication Number Publication Date
MA57215B1 true MA57215B1 (en) 2022-12-30

Family

ID=84578009

Family Applications (1)

Application Number Title Priority Date Filing Date
MA57215A MA57215B1 (en) 2020-09-03 2021-08-06 Compounds comprising a nitrile as antivirals for the treatment of coronavirus infection

Country Status (2)

Country Link
AR (1) AR123111A1 (en)
MA (1) MA57215B1 (en)

Also Published As

Publication number Publication date
AR123111A1 (en) 2022-11-02

Similar Documents

Publication Publication Date Title
MX2021013679A (en) Nitrile-containing antiviral compounds.
CR20210563A (en) Compounds and methods for the treatment of covid-19
TNSN08445A1 (en) TRIAZOLOPYRAZINE DERIVATIVES USEFUL AS ANTICANCER AGENT
BR112022026899A2 (en) COMPOUND REPRESENTED BY FORMULA (I) OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT OR PREVENTION OF A VIRAL INFECTION, METHOD OF INHIBITING VIRAL PROTEASE 3C OR VIRAL PROTEASE 3CL IN A MAMMAL, AND METHOD OF TREATMENT OF A DISORDER RESPIRATORY
TNSN04246A1 (en) BENZOCONDENSIC HETEROARYLAMIDE DERIVATIVES OF THIENOPYRIDINES USEFUL AS THERAPEUTIC AGENTS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND METHODS FOR THEIR USE
MA27774A1 (en) PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS
MA27568A1 (en) PYRROLOPYRIMIDINE DERIVATIVES
MA42295B1 (en) Benzoxazepin oxazolidinone compounds and method for their use
MA30325B1 (en) COMPOUNDS THAT POTENTIATE THE AMPA RECEPTOR AND THEIR USES IN MEDICINE
MA30089B1 (en) (Arylsulfonyl) -PYRASOLOPIPERIDINES
MA31036B1 (en) NON-NUCLEOSIDIC INHIBITORS OF REVERSE TRANSCRIPTASE
MA27908A1 (en) THERAPEUTIC AGENTS USEFUL FOR THE TREATMENT OF PAIN
MA29213B1 (en) QUINOLONES WITH MACROLONES SUBSTITUTION - AMINO
MA30532B1 (en) CONDENSED TRICYCLIC SULFONAMIDES GAMMA SECRETASE INHIBITORS
MA29630B1 (en) ACTIVE PHARMACEUTICAL INGREDIENT OF CANNABINOID FOR IMPROVED DOSAGE FORMS
MA27389A1 (en) NEW BENZIMIDAZOLE DERIVATIVES USEFUL AS ANTIPROLIFERATIVE AGENTS.
MA26723A1 (en) NOVEL OXAMIC ACIDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
MA29335B1 (en) N- (N-SULFONYLAMINOMETHYL) CYCLOPROPANECARBOXAMIDE DERIVATIVES USEFUL FOR THE TREATMENT OF PAIN
MA35422B1 (en) Amine-substituted imidazopyridazines
MA27347A1 (en) HIV PROTEASE INHIBITORS, COMPOSITIONS CONTAINING THEM, PHARMACEUTICAL USES THEREOF AND MATERIALS FOR THEIR SYNTHESIS
MA27751A1 (en) Substituted 4-phenyltetrahydroisoquinolines, process for producing these compounds, use of these compounds as medicaments and medicament containing such compounds
BR112023002573A2 (en) COMPOUND, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT OR PREVENTION OF VIRAL INFECTION AND RESPIRATORY DISORDERS AND METHOD OF INHIBITION OF VIRAL PROTEASE
TNSN07145A1 (en) 2-AMIDO-4-PHENYLTHIAZOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE
MA28742B1 (en) PYRIDO-PYRIMIDINE DERIVATIVES, THEIR PREPARATION, THEIR THERAPEUTIC APPLICATION
TNSN00235A1 (en) NEW HETEROCYCLO-ALKYLSULFONYLPYRAZOLE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM